Activity 4L. Management of Treatment Interruption After Missing 8-20 Days PDF Share Learning Objective Performance Indicators Provide a rationale for treating all people with HCV except persons with less than a 12-month life expectancy Adhere to inclusion and exclusion criteria for who is eligible to receive simplified HCV treatment Choose an appropriate recommended regimen for simplified HCV treatment Conduct laboratory monitoring for persons receiving simplified HCV treatment, including assessment for sustained virologic response Manage incomplete treatment adherence based on time into treatment and number of days of missed doses Activity QuestionYou should answer this question after completing the activity. You must answer all of the questions before checking your work. This activity has a Check on Learning question. - Show Question A 47-year-old man with chronic HCV genotype 1 and compensated cirrhosis is taking a scheduled 12-week HCV treatment course of sofosbuvir-velpatasvir. At week 7 of the treatment she has a febrile diarrheal illness and he stops taking sofosbuvir-valpatasvir for 9 days. He is seen in clinic and diagnosed with shigella on the same day as the clinic visit based on a multiplex enteric stool PCR test. Treatment for shigella is started and he is told to restart sofosbuvir-velpatasvir. An HCV RNA level is drawn and the result returns 2 days later as undetectable.What should be recommended regarding the sofosbuvir-velpatasvir treatment? Complete the 12-week treatment course (complete 84 total days of treatment) Start the treatment over from the beginning Start the treatment over but use a 12-week treatment course of glecaprevir-pibrentasvir Stop treatment now and recheck an HCV RNA in 12-16 weeks Share by e-mail From:Enter your e-mail address To: Enter the e-mail address of the recipient Your Message: Check-On-LearningQuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
